Tuberous Sclerosis Complex-associated Refractory Seizures Clinical Trials

Tuberous Sclerosis Complex-associated Refractory Seizures

Explore clinical trials studying Tuberous Sclerosis Complex-associated Refractory Seizures. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Tuberous Sclerosis Complex-associated Refractory Seizures trial results

Completed

A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures

NCT01713946

Conditions: Tuberous Sclerosis Complex-associated Refractory Seizures
Locations: University of Alabama at Birmingham SC Birmingham, Alabama, United States

TGen/APNNA Phoenix, Arizona, United States

University of California at Los Angeles SC Los Angeles, California, United States

Children's Hospital Oakland SC Oakland, California, United States

View all 104 locations

View Trial Details